Inhibitor Therapeutics, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inhibitor Therapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2025-12-31 was 0.00 shares.
- Inhibitor Therapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2025-09-30 was 0.00 shares.
- Inhibitor Therapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2024-12-31 was 0.00 shares.
- Inhibitor Therapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2024-09-30 was 0.00 shares.
- Inhibitor Therapeutics, Inc. stock issued during period, shares, new issues for fiscal 2025 was 215.00K shares, a 25.86% decline from fiscal 2024.
- Inhibitor Therapeutics, Inc. stock issued during period, shares, new issues for fiscal 2024 was 290.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 215.00K shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 290.00K shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | |
| 2024-06-30 | 20.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | |
| 2024-03-31 | 270.00K shares 10-Q · filed 2025-05-14 |